Medical marijuana; medical marijuana transporter license; providing issuance of licenses for premises under certain circumstances; directing creation of inventory manifests documenting certain information; allowing certain licensees to maintain and operate warehouses under certain conditions; effective date; emergency.
HB2807 makes several changes to Oklahoma’s medical marijuana regulatory framework, with a primary focus on transporter licenses, warehouse operations, and product tracking. It authorizes medical marijuana transporter licensees to maintain and operate one or more warehouses in the state, but only with an annual permit for each warehouse location and approval by the Oklahoma Medical Marijuana Authority (OMMA). The bill also requires OMMA to determine that each proposed warehouse site is physically and technically suitable, and it allows the agency to deny permits for unsuitable locations.
The bill expands and clarifies inventory and transport documentation requirements. Transporters must use the state seed-to-sale tracking system to create shipping inventory manifests that include detailed information about the origin, destination, quantities, dates, personnel, and any temporary storage at transporter premises or warehouses. Receiving licensees must refuse product without a manifest, and both originating and receiving licensees, including transporter warehouses, must keep manifests and quantity logs for seven years. The bill also continues existing requirements for GPS-tracked vehicles, secured transport, and transporter agent licensing and background checks.
HB2807 also updates related provisions governing medical marijuana facility owners and employees by reaffirming fingerprint-based criminal background checks through the Oklahoma State Bureau of Investigation and the FBI. In addition, it modifies the pre-packaging law for medical marijuana products by excluding drinks from the pre-packaging requirement for flower, trim, shake, kief, and other flower-based products, while preserving OMMA’s rulemaking authority over packaging and returns of defective or hazardous products.
The bill’s impact on state law is to tighten oversight of the medical marijuana supply chain while giving transporters more formal authority to use warehouses for temporary storage and distribution. It amends multiple sections of the Oklahoma Medical Marijuana and Patient Protection Act and related 2024 laws, affecting transporters, warehouses, growers, processors, dispensaries, research and education facilities, and OMMA’s licensing and inspection duties. The bill takes effect June 1, 2025, and contains an emergency clause.
The overall sentiment appears strongly favorable and largely noncontroversial. The bill advanced with broad bipartisan support in both chambers, including unanimous or near-unanimous committee votes and overwhelming floor votes, though the House final vote included a small number of dissenting members. The main points of contention, to the extent reflected in the legislative history, likely centered on regulatory burden versus operational flexibility: the bill imposes more detailed tracking, storage, and background-check requirements while also expanding warehouse options for licensed transporters.
HB2807 amends the Oklahoma Medical Marijuana and Patient Protection Act to add a formal warehouse-permit structure for transporter licensees, expand OMMA’s approval and inspection authority, and require more detailed seed-to-sale inventory manifests and record retention. It also updates background-check provisions for owners and employees of medical marijuana facilities and revises the pre-packaging statute to exclude drinks from the flower-product pre-packaging requirement. These changes directly affect licensed transporters, warehouses, dispensaries, growers, processors, research and education facilities, and OMMA enforcement and licensing operations.
The bill was received positively throughout the legislative process, with strong committee support and overwhelmingly favorable floor votes in both the House and Senate. The absence of recorded committee testimony suggests limited public controversy in the available record. The final House vote included a small minority of no votes, indicating some residual concern, but the overall pattern shows broad agreement on the need to clarify and regulate transporter warehousing and product tracking in the medical marijuana market.
The likely areas of contention were the balance between tighter regulation and business flexibility. Supporters appear to have favored clearer rules for transporter warehouses, manifests, and background checks to improve traceability and enforcement, while any opponents may have been concerned about added compliance costs, OMMA discretion in approving or denying warehouse permits, and the administrative burden on licensees. The bill’s exclusion of drinks from the pre-packaging requirement may also have been a technical point of interest for processors and dispensaries, but no specific committee debate is available in the record.